Physician profile
Natalie L Ikeman
NPI 1861767154
$170,187.85
in general payments reported to CMS, 2019-2025
9 companies · $109K in 2025
The $109K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $104 · 2024: $61K · 2025: $109K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $112K · Travel and Lodging: $48K · Food and Beverage: $5,512 · Consulting Fee: $4,600 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $112,054.88 |
| Travel and Lodging | $47,891.70 |
| Food and Beverage | $5,512.19 |
| Consulting Fee | $4,600.00 |
| Education | $129.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $110,277.95 | 2023-2025 | Zepbound, Taltz, Mounjaro |
| Novo Nordisk INC | $59,695.41 | 2023-2025 | Wegovy |
| Vivus LLC | $78.61 | 2024 | Qsymia |
| Boston Scientific Corporation | $28.93 | 2025 | Apollo Esg System |
| Ipsen Biopharmaceuticals, INC | $27.92 | 2025 | Iqirvo |
| Organon LLC | $26.69 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $24.93 | 2024 | Dupixent |
| Phathom Pharmaceuticals, INC. | $13.73 | 2024 | Voquezna |
| Intercept Pharmaceuticals, INC. | $13.68 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Ikeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.